Intended for healthcare professionals

Feature Hidden Data

Putting GlaxoSmithKline to the test over paroxetine

BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f6754 (Published 12 November 2013) Cite this as: BMJ 2013;347:f6754

Re: Putting GlaxoSmithKline to the test over paroxetine

Below is the exchange of letters between Jon Jureidini and GlaxoSmithKline since November 15, 2013, which continues the earlier discussion and in which Jureidini signals concerns about whose responsibility it is to alert trial participants to harm they may have experienced in the course of the clinical trials.

Competing interests: As declared in the article (BMJ 2013;347:f6754).

28 February 2014
Peter Doshi
associate editor
BMJ
London WC1H 9JR, UK